<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Strain, strain <break/>background <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL4-3</sub></td><td>Other</td><td/><td>Replication competent <break/>HIV-1 virus particles <break/>produced from pNL4-3 <break/>plasmid in HEK293T <break/>producing cells; <break/>laboratory adapted <break/>HIV-1 strain</td></tr><tr><td>Strain, strain <break/>background <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL-lucE-R+VSVg</sub></td><td>Other</td><td/><td>Replication incompetent <break/>HIV-1 virus particles <break/>produced from pNL-luc. <break/>E-R+and pMD.G plasmids <break/>in HEK293T producing <break/>cells; laboratory adapted <break/>HIV-1 strain pseudotyped <break/>with VSV glycoprotein</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL4-3</sub> IN (K14A)</td><td>Other</td><td/><td>Replication competent <break/>HIV-1 virus particles <break/>containing the mutation <break/>K14A in the Integrase ORF</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL4-3</sub> IN <break/>(Y15A)</td><td>Other</td><td/><td>Replication competent <break/>HIV-1 virus particles <break/>containing the mutation <break/>Y15A in the Integrase ORF</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL4-3</sub> IN <break/>(T210&#160;+&#160;Pro)</td><td>Other</td><td/><td>Replication competent <break/>HIV-1 virus particles <break/>containing the mutation <break/>T210&#160;+&#160;Pro in the <break/>Integrase ORF</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL4-3</sub> IN <break/>(N222K)</td><td>Other</td><td/><td>Replication competent <break/>HIV-1 virus particles <break/>containing the mutation <break/>N222K in the Integrase <break/>ORF</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL-lucE-R+</sub> <break/><sub>N155H/K156NVSVg</sub></td><td>Other</td><td/><td>Replication incompetent, <break/>VSVg pseudotyped HIV-1 <break/>virus particles containing <break/>the following mutations <break/>in the IN ORF: N155H/K156N</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>Retroviridae</italic>)</td><td>HIV-1<sub>NL-lucE-R+</sub> <break/><sub>N155H/K156N/K211R/E212TVSVg</sub></td><td>Other</td><td/><td>Replication incompetent, <break/>VSVg pseudotyped HIV-1 <break/>virus particles containing <break/>the following mutations in <break/>the IN ORF: <break/>N155H/K156N/K211R/ <break/>E212T</td></tr><tr><td>Cell line <break/>(<italic>H.sapiens</italic>)</td><td>HeLa</td><td>ATCC</td><td>ATCC CCL-2</td><td/></tr><tr><td>Cell line <break/>(<italic>H.sapiens</italic>)</td><td>Hek293T</td><td>ATCC</td><td>ATCC CRL-3216</td><td/></tr><tr><td>Cell line (<italic>H.sapiens</italic>)</td><td>TZM-bl</td><td>NIH AIDS Reagent <break/>Program</td><td>NIH AIDS Reagent <break/>Program: 8129</td><td>The reagent was obtained <break/>through the NIH AIDS <break/>Reagent Program, Division <break/>of AIDS, NIAID, NIH: TZM-bl <break/>cells (Cat# 8129) from <break/>Dr. John C Kappes, <break/>and Dr. Xiaoyun Wu</td></tr><tr><td>Cell line <break/>(H.sapiens)</td><td>TZM-bl PPIA(-/-)</td><td><xref ref-type="bibr" rid="bib32">Francis and Melikyan, 2018</xref></td><td/><td/></tr><tr><td>Cell line <break/>(<italic>H.sapiens</italic>)</td><td>MT-4</td><td>NIH AIDS Reagent <break/>Program</td><td>NIH AIDS Reagent <break/>Program: 120</td><td>The reagent was obtained <break/>through the NIH AIDS <break/>Reagent Program, Division <break/>of AIDS, NIAID, NIH: MT-4 <break/>from Dr. Douglas Richman</td></tr><tr><td>Biological <break/>sample (<italic>Rat</italic>)</td><td>Sprague-Dawley <break/>rat liver microsomes</td><td>Xenotech LLC</td><td>Xenotech LLC: 1510115</td><td>Pool of 500, male; 20 mg/mL</td></tr><tr><td>Biological <break/>sample (<italic>H.sapiens</italic>)</td><td>Human Liver <break/>Microsomes</td><td>Xenotech LLC</td><td>Xenotech LLC: 1610016</td><td>Pool of 50, mixed <break/>gender; 20 mg/mL</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL4-3 (plasmid)</td><td valign="bottom"><xref ref-type="bibr" rid="bib1">Adachi et al., 1986</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL4-3 IN <break/>(K14A) (plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL4-3 to generate <break/>IN K14A mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL4-3 IN <break/>(Y15A) (plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL4-3 to generate IN <break/>Y15A mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL4-3 IN <break/>(T210&#160;+&#160;Pro) (plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL4-3 to generate <break/>IN T210&#160;+&#160;Pro mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL4-3 IN <break/>(T222K) (plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL4-3 to generate IN <break/>T222K mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL-luc.E-R+ <break/>(plasmid)</td><td><xref ref-type="bibr" rid="bib14">Connor et al., 1995</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL-luc.E-R+N <break/>155 H/K156N (plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL-luc.E-R+to generate <break/>IN N155H/K156N mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pNL-luc.E-R+N155 <break/>H/K156N/K211R/E212T <break/>(plasmid)</td><td valign="bottom">This paper</td><td/><td>Site-directed mutagenesis <break/>in pNL-luc.E-R+to generate <break/>IN N155H/K156N/K211R/ <break/>E212T mutant</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pMD.G (plasmid)</td><td valign="bottom"><xref ref-type="bibr" rid="bib52">Naldini et al., 1996</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>Vpr-INmNeon <break/>Green (INmNG)</td><td valign="bottom"><xref ref-type="bibr" rid="bib32">Francis and Melikyan, 2018</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>CypA-DsRed</td><td valign="bottom"><xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>; <break/><xref ref-type="bibr" rid="bib32">Francis and Melikyan, 2018</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pHIVeGFP-deltaEnv</td><td valign="bottom"><xref ref-type="bibr" rid="bib32">Francis and Melikyan, 2018</xref></td><td/><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>Recombinant <break/>IN (pET-15b)</td><td valign="bottom"><xref ref-type="bibr" rid="bib44">Larue et al., 2012</xref></td><td/><td>All the mutations were <break/>carried out by site <break/>directed mutagenesis in IN <break/>coding region of pET-15b</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>Recombinant IN <break/>domains: NTD-CCD, <break/>CCD and CCD-CTD <break/>(pET-15b)</td><td valign="bottom">This paper</td><td/><td>Wild type NL4-3 IN domains <break/>were constructed by site <break/>directed mutagenesis from <break/>pET-15b truncated IN <break/>domains containing <break/>solubilizing mutants <break/>(<xref ref-type="bibr" rid="bib44">Larue et al., 2012</xref>)</td></tr><tr><td>Recombinant <break/>DNA reagent</td><td>Recombinant <break/>LEDGF (pLEDGF)</td><td valign="bottom"><xref ref-type="bibr" rid="bib64">Tsiang et al., 2009</xref></td><td/><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>p24 ELISA</td><td>Zeptometrix</td><td>Zeptometrix: 0801111</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>MycoscopeMycoplasm <break/>PCR detection kit</td><td>Genlantis</td><td>Genlantis: MY01100</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>CellTiter-Glo</td><td>Promega <break/>Biosciences Inc</td><td>Promega <break/>Biosciences Inc: G7571</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>Luciferase Assay <break/>System</td><td>Promega <break/>Biosciences Inc</td><td>Promega <break/>Biosciences Inc: E1500</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>QuikChange XL site <break/>directed mutagenesis <break/>kit</td><td>Agilent</td><td>Agilent: 200516</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>QuikChange XL II <break/>site directed <break/>mutagenesis&#160;kit</td><td>Agilent</td><td>Agilent: 200522</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>LANCE Europium- <break/>streptavidin for HTRF <break/>assay</td><td>PerkinElmer</td><td>PerkinElmer: AD0062</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>Reporter Lysis <break/>buffer</td><td>Promega <break/>Biosciences Inc</td><td>Promega <break/>Biosciences Inc: E3971</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>X-treme Gene <break/>HP</td><td>Roche</td><td>Roche: 6366244001</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>KF116</td><td><xref ref-type="bibr" rid="bib58">Sharma et al., 2014</xref></td><td/><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>BI224436</td><td>MedChemExpress</td><td>MedChem <break/>Express: HY-18595</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>nicotinamide <break/>adenine dinucleotide <break/>phosphate (NADPH)</td><td>Sigma-Aldrich <break/>Chemical Company</td><td>Sigma-Aldrich: <break/>10107824001</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Verapamil <break/>Hydrochloride</td><td>Sigma-Aldrich <break/>Chemical Company</td><td>Sigma-Aldrich: <break/>V4629</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Domperidone</td><td>Sigma-Aldrich <break/>Chemical Company</td><td>Sigma-Aldrich: <break/>D122</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Chlorpromazine <break/>hydrochloride</td><td>Sigma-Aldrich <break/>Chemical Company</td><td>Sigma-Aldrich: <break/>C8138</td><td/></tr><tr><td>Software, <break/>algorithm</td><td>HKL 3000</td><td>HKL 3000 <break/>(<ext-link ext-link-type="uri" xlink:href="http://hkl-xray.com">http://hkl-xray.com</ext-link>)</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015023">SCR_015023</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Phenix</td><td>Phenix <break/>(<ext-link ext-link-type="uri" xlink:href="https://www.phenix-online.org/">https://www.phenix-online.org/</ext-link>)</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014224">SCR_014224</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Coot</td><td>Coot <break/>(<ext-link ext-link-type="uri" xlink:href="http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot">http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot</ext-link>)</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014222">SCR_014222</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>HADDOCK</td><td><xref ref-type="bibr" rid="bib20">Dominguez et al., 2003</xref>, <break/><xref ref-type="bibr" rid="bib68">van Zundert et al., 2016</xref></td><td valign="bottom"/><td/></tr><tr><td>Software, <break/>algorithm</td><td>ImageJ</td><td valign="bottom">ImageJ <break/>(<ext-link ext-link-type="uri" xlink:href="https://imagej.net">https://imagej.net</ext-link>)</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td valign="bottom">OriginLab</td><td>OriginLab <break/>software (<ext-link ext-link-type="uri" xlink:href="https://www.originlab.com">https://www.originlab.com</ext-link>)</td><td/><td/></tr><tr><td>Software, <break/>algorithm</td><td valign="bottom">ICY image analysis <break/>software</td><td>ICY image analysis <break/>software (<ext-link ext-link-type="uri" xlink:href="https://icy.bioimageanalysis.org">https://icy.bioimageanalysis.org</ext-link>)</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010587">SCR_010587</ext-link></td><td/></tr></tbody></table></table-wrap>